NKGen Biotech to Present Troculeucel Mechanism Data in Alzheimer’s and Frontotemporal Dementia at the Neuroimmunology Drug Development Summit
Go back to NKGen Biotech to Present Troculeucel Mechanism Data in Alzheimer’s and Frontotemporal Dementia at the Neuroimmunology Drug Development Summit| (NASDAQ: NKGN) | Delayed: 0.19 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.19 | 52 Week High | $ | |||
| Open | $0.19 | 52 Week Low | $ | |||
| Day High | $0.19 | P/E | N/A | |||
| Day Low | $0.19 | EPS | $ | |||
| Volume | 9,221 | |||||

